Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

SHE:000623 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 29, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	18,723	20,653	17,098	17,020	21,034	18,957
Market Cap Growth	13.83%	20.79%	0.46%	-19.09%	10.96%	-1.39%
Enterprise Value	18,705	20,126	16,961	17,193	19,596	17,652
Last Close Price	15.97	17.27	14.30	13.89	16.78	14.77
PE Ratio	9.87	13.31	11.71	9.56	11.81	11.09
PS Ratio	7.89	7.91	4.96	5.93	9.13	8.42
PB Ratio	0.63	0.71	0.62	0.65	0.84	0.81
P/TBV Ratio	0.65	0.72	0.64	0.66	0.86	0.82
P/FCF Ratio	-	-	-	111.32	1821.95	116.28
P/OCF Ratio	146.07	347.21	251.22	40.15	64.75	48.56
EV/Sales Ratio	7.89	7.71	4.92	5.99	8.51	7.84
EV/EBITDA Ratio	-	442.54	49.91	52.66	97.79	136.07
EV/EBIT Ratio	-	-	126.08	132.35	3339.39	-
EV/FCF Ratio	-181.29	-	-	112.45	1697.40	108.28
Debt / Equity Ratio	0.08	0.08	0.11	0.11	0.10	0.11
Debt / EBITDA Ratio	107.82	31.37	8.23	8.41	12.45	19.13
Debt / FCF Ratio	-	-	-	19.56	226.58	15.22
Asset Turnover	0.07	0.08	0.11	0.10	0.08	0.09
Inventory Turnover	1.57	1.77	2.02	1.93	1.95	1.70
Quick Ratio	1.50	1.57	1.08	2.25	3.89	4.01
Current Ratio	1.87	1.96	1.29	2.70	4.35	4.47
Return on Equity (ROE)	6.51%	5.35%	5.37%	7.01%	7.29%	7.36%
Return on Assets (ROA)	-0.40%	-0.31%	0.27%	0.27%	0.01%	-0.15%
Return on Capital (ROIC)	-0.42%	-0.32%	0.28%	0.29%	0.01%	-0.16%
Return on Capital Employed (ROCE)	-	-	0.50%	0.40%	0.00%	-
Earnings Yield	10.28%	7.51%	8.54%	10.46%	8.46%	9.01%
FCF Yield	-0.55%	-1.04%	-2.06%	0.90%	0.06%	0.86%
Dividend Yield	3.76%	2.90%	4.20%	2.16%	1.79%	1.35%
Payout Ratio	51.69%	68.33%	27.44%	21.21%	14.36%	14.76%
Buyback Yield / Dilution	6.51%	9.08%	0.46%	-3.36%	1.39%	0.28%
Total Shareholder Return	10.27%	11.98%	4.66%	-1.20%	3.17%	1.63%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.